INVO Fertility price to book ratio IVF
Market value divided by the book value of the company's net assets, since 2021.
- Today, Nov 2, 2026
- 0.1×
- 6-year median
- 1.0×
- Against its 6-year history
- 14th
- percentile: 0 is its lowest day, 100 its highest
- 6-year range
- 0.0× to 96.6×
- Peer median
- 0.2×
INVO Fertility's price to book ratio is 0.1× as of Nov 2, 2026.
That is below its 6-year median of 1.0×, lower than on 86% of days in the last 6 years.
Over that time it ranged from 0.0× in Oct 2026 to 96.6× in Jun 2024.
The median for 10 medical instruments and supplies stocks of a similar size is 0.2×.
Price to book ratio over time
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 0.1× | 0.0× | 0.1× |
| 2025 | 0.1× | 0.0× | 0.7× |
| 2024 | 0.6× | 0.5× | 96.6× |
| 2023 | 2.2× | 1.1× | 15.3× |
| 2022 | 1.0× | 0.4× | 4.1× |
| 2021 | 3.8× | 1.7× | 4.4× |
Against its peers
Companies in Medical - Instruments & Supplies nearest INVO Fertility's size, closest first, today.
| Company | Price to book ratio |
|---|---|
| IVFINVO Fertility | 0.1× |
| BBLGBone Biologics | 0.2× |
| TNONTenon Medical | n/m |
| VJETFlyte Aviation | 0.0× |
| AMIXAutonomix Medical | 0.5× |
| NXGLNexgel | 0.4× |
| ADGMAdagio Medical | n/m |
| XAIRBeyond Air | 1.1× |
| VVOSVivos Therapeutics | n/m |
| CODXCo-Diagnostics | 0.2× |
| BJDXBluejay Diagnostics | 0.1× |
| Peer median | 0.2× |
What the price to book ratio tells you
Market value divided by the accounting value of the company's net assets. Below 1 means the market values the business at less than what it owns on paper.
Book value misses brands, software and people, so asset-light companies always look expensive on it. Most useful for banks and industrials.
More on INVO Fertility
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.